ONCODESIGN PRECISION MEDICIN (ALOPM.PA) Stock Overview
EPA:ALOPM - FR001400CM63 - Common Stock
ALOPM.PA Key Statistics, Chart & Performance
The current stock price of ALOPM.PA is 0.427 EUR. In the past month the price decreased by -2.51%. In the past year, price decreased by -58.54%.
ALOPM.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 19.78 | 315.51B | ||
| AMG.DE | AMGEN INC | 12.88 | 128.96B | ||
| GIS.DE | GILEAD SCIENCES INC | 14.97 | 122.63B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 23.24 | 86.04B | ||
| ARGX.BR | ARGENX SE | 87.92 | 39.66B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 21.53B | ||
| IDP.DE | BIOGEN INC | 8.93 | 17.87B | ||
| 0QF.DE | MODERNA INC | N/A | 8.02B | ||
| 1MRNA.MI | MODERNA INC | N/A | 8.02B | ||
| 1EXAS.MI | EXACT SCIENCES CORP | N/A | 7.29B | ||
| ABVX.PA | ABIVAX SA | N/A | 5.64B | ||
| 1VKTX.MI | VIKING THERAPEUTICS INC | N/A | 2.59B |
Related stock screener links
About ALOPM.PA
Company Profile
Oncodesign Precision Medicine (OPM) SAS manufactures precision medicine. The company is headquartered in Dijon, Bourgogne-Franche-Comte and currently employs 18 full-time employees. The company went IPO on 2022-10-05. The company aims at providing effective diagnostic and therapeutic solutions for resistant and metastatic cancers. The Company’s technologies from Oncodesign, are OncoSNIPER for the selection of therapeutic targets using artificial intelligence; Nanocyclix for the design and selection of macrocyclic small molecule kinase inhibitors and Theranostics for the design and selection of radiolabeled biological molecules for systemic radiotherapy. The company focuses on the research and development of therapeutic and diagnostic solutions in the clinical and preclinical areas of medical oncology.
Company Info
ONCODESIGN PRECISION MEDICIN
18 Rue Jean Mazen
Dijon BOURGOGNE-FRANCHE-COMTE FR
Employees: 18
ONCODESIGN PRECISION MEDICIN / ALOPM.PA FAQ
What is the stock price of ONCODESIGN PRECISION MEDICIN today?
The current stock price of ALOPM.PA is 0.427 EUR.
What is the ticker symbol for ONCODESIGN PRECISION MEDICIN stock?
The exchange symbol of ONCODESIGN PRECISION MEDICIN is ALOPM and it is listed on the Euronext Paris - Matif exchange.
On which exchange is ALOPM.PA stock listed?
ALOPM.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for ONCODESIGN PRECISION MEDICIN stock?
9 analysts have analysed ALOPM.PA and the average price target is 2.04 EUR. This implies a price increase of 377.75% is expected in the next year compared to the current price of 0.427. Check the ONCODESIGN PRECISION MEDICIN stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ONCODESIGN PRECISION MEDICIN worth?
ONCODESIGN PRECISION MEDICIN (ALOPM.PA) has a market capitalization of 7.77M EUR. This makes ALOPM.PA a Nano Cap stock.
How many employees does ONCODESIGN PRECISION MEDICIN have?
ONCODESIGN PRECISION MEDICIN (ALOPM.PA) currently has 18 employees.
What are the support and resistance levels for ONCODESIGN PRECISION MEDICIN (ALOPM.PA) stock?
ONCODESIGN PRECISION MEDICIN (ALOPM.PA) has a support level at 0.43 and a resistance level at 0.44. Check the full technical report for a detailed analysis of ALOPM.PA support and resistance levels.
Is ONCODESIGN PRECISION MEDICIN (ALOPM.PA) expected to grow?
The Revenue of ONCODESIGN PRECISION MEDICIN (ALOPM.PA) is expected to grow by 151.06% in the next year. Check the estimates tab for more information on the ALOPM.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ONCODESIGN PRECISION MEDICIN (ALOPM.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ALOPM.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ALOPM.PA, evaluating the profitability, health, valuation and growth aspects
- ONCODESIGN PRECISION MEDICIN (ALOPM.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ONCODESIGN PRECISION MEDICIN (ALOPM.PA) Sales and EPS estimates to see what analysts future expectations are.
- ONCODESIGN PRECISION MEDICIN (ALOPM.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ONCODESIGN PRECISION MEDICIN (ALOPM.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- ONCODESIGN PRECISION MEDICIN (ALOPM.PA) Stock Chart to make your own analysis
- ONCODESIGN PRECISION MEDICIN (ALOPM.PA) Latest news and press-releases to stay up to date.
Does ONCODESIGN PRECISION MEDICIN (ALOPM.PA) stock pay dividends?
ALOPM.PA does not pay a dividend.
What is the Price/Earnings (PE) ratio of ONCODESIGN PRECISION MEDICIN (ALOPM.PA)?
ONCODESIGN PRECISION MEDICIN (ALOPM.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.3).
ALOPM.PA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ALOPM.PA. When comparing the yearly performance of all stocks, ALOPM.PA is a bad performer in the overall market: 88.89% of all stocks are doing better.
ALOPM.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALOPM.PA. ALOPM.PA may be in some trouble as it scores bad on both profitability and health.
ALOPM.PA Financial Highlights
Over the last trailing twelve months ALOPM.PA reported a non-GAAP Earnings per Share(EPS) of -0.3. The EPS increased by 18.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALOPM.PA Forecast & Estimates
9 analysts have analysed ALOPM.PA and the average price target is 2.04 EUR. This implies a price increase of 377.75% is expected in the next year compared to the current price of 0.427.
For the next year, analysts expect an EPS growth of 95% and a revenue growth 151.06% for ALOPM.PA